The next meeting of the Transparency Council will be held on Monday, October 3.
The agenda includes:
Preparation of an opinion on the legitimacy of introducing changes to the draft drug program B.101. "Treatment with pcsk-9 inhibitors or inclisiran in patient...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
